Page 34 - Indian Stock Markets

This Rekha Jhunjhunwala portfolio stock nears record low; down 29% in 2 mth

Star Health and Allied Insurance Company shares hit a 52-week low of Rs 463, down 4% in intra-day deal and trading near its all-time low of Rs 451.10 hit on January 30, 2023.

Aarti Ind, Auro Pharma, Trent stocks see short build-up; trading guide here

F&O data shows, on Friday Aarti Industries, Aurobindo Pharma and Trent saw a dip in share price alongside rise in open interest; thus implying short build-up at these counters.

Ashok Leyland up 4% after targeting Ebitda break-even for its arm in FY25

Hinduja expects Switch India to achieve Ebitda (earnings before interest, taxes, depreciation, and amortisation) break-even during the current financial year

Nifty rebound attempt fizzles, sellers reinforce resistance; shows F&O data

F&O cues for Nov 11: Nifty's outlook has shifted to a bearish-to-sideways bias, as multiple rally attempts have been thwarted by sellers, says Dhupesh Dhameja of SAMCO Securities.

Market Close Highlights: Sensex ends 50 pts lower at 79,500; Nifty at 24,150; PSB, Oil drag, IT up

Stock Market Highlights: Benchmark Indian equity indices ended in the red for the second straight session on Friday, weighed most by financial and OMC stocks

SBI Q2 results preview: Profit may rise upto 17%, provisions could shoot up

SBI Q2 preview: SBI, India's biggest state-owned bank, is scheduled to report its financial results for quarter-ended (Q2 FY25) and half-year ended (H1 FY25) on September 30, 2024 on November 8, 2024

FIIs add fresh shorts in Nifty futures; F&O data hints at cautious stance

F&O cues for Nov 08: According to the options data, the max pain level for the Nifty now stands at 24,200, and for Bank Nifty at 52,100; says Dhupesh Dhameja of SAMCO Securities.

Market today: Fed rate cut; Swiggy, ACME IPO last day; Sagility allotment

Wall Street closed at record levels on Thursday, after the US Fed cut interest rate by 25 bps. Announcements regarding more stimulus measure from China, quarterly results, and macroeconomic data to be

BS BFSI Summit: Market gurus say valuations limit near-term upside

BS BFSI Summit: There is limited room for PE multiples to move up and return expectations going ahead have to be moderate, analysts said at the Business Standard BFSI Insight Summit

Why Sensex fell 959 pts, Nifty 302 pts, after Trump's US election victory

BSE Sensex dropped by 1.19 per cent or 958.79 points to 79,419.34, before settling at 79,541.79. Similarly, the NSE Nifty50 tanked 1.24 per cent or 305 points to 24,179.05, before ending at 24,199.35

Stock Market Close Highlights: Sensex sheds 836pts; Nifty ends below 24,200; all sectors end in red

Share Market Highlights: Apollo Hospitals, HDFC Life, SBI, and TCS were the only four Nifty50 constituent stocks to manage to settle in the green on Thursday

Eureka Forbes share price rallies 6% as Q2 profit zooms 85% YoY

The rise in Eureka Forbes share price came after the company posted a stellar set of September quarter results

India equity clearing corporations need diverse ownership: Sebi official

In June, Sebi set up a committee to review the ownership structure of clearing corporations to ensure greater independence and resilience

Nifty bias shifts to 'Buy on Dips', max pain seen at 24,400; shows F&O data

F&O cues for Nov 07: Meanwhile, Bank Nifty PCR dipped to 0.72, reflecting a shift towards a cautious outlook, says Dhupesh Dhameja of SAMCO Securities.

Market Close Highlights: Sensex adds 900pts; Nifty ends near 24,450; IT stocks soar on Trump victory

Stock Market Highlights: As many as 41 out of 50 constituent stocks of Nifty50 ended higher, led by BEL, Adani Enterprises, TCS, HCL Tech, and Wipro

Trump Trade: Strategies for Indian IT, Pharma indices post US elections

Analysts believe that Indian export-oriented sectors such as pharma and IT may experience challenges under Donald Trump's rule. Here's how Nifty IT and Pharma indices are placed on charts.

Interest rate cut cycle to pause if Trump wins US election 2024: ICICI Sec

US election results: The brokerage believes Donald Trump's protectionist policies such as higher tariffs, and policies against immigration, could be a curve ball for global trade

Mankind Pharma up 6% as PAT rises 29%, margins up 220 bps in Q2FY25

Mankind Pharma declared its September quarter numbers on Tuesday after market hours

Market Highlights: Banks, metals lift Sensex 694 pts, Nifty atop 24 200; US election results eyed

Stock Market Highlights, Nov 5, Tuesday: In the broader markets, the BSE MidCap and the BSE SmallCap indices edged 0.4 per cent higher each.

Tube Investment down 5% as Q2 profit declines 14%, expenses rise 18%

The engineering division of Tube investment clocked a revenue of Rs 1,323 crore compared to Rs 1,274 crore in the corresponding period in the preceding fiscal